uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
QOL Improvements in NETTER-1 Phase III Trial in Patients With Progressive Midgut Neuroendocrine Tumors
H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA.
Montefiore Med Ctr, New York, NY USA.
Univ Texas MD Anderson Canc Ctr, Houston, TX, USA.
Dana Farber Canc Inst, Boston, MA, USA.
Show others and affiliations
2018 (English)In: Pancreas, ISSN 0885-3177, E-ISSN 1536-4828, Vol. 47, no 3, p. 355-355Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2018. Vol. 47, no 3, p. 355-355
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-351594DOI: 10.1097/MPA.0000000000000997ISI: 000426086300102OAI: oai:DiVA.org:uu-351594DiVA, id: diva2:1210632
Conference
The 10th Annual Meeting of the North American Neuroendocrine Tumor Society, October 19–21, 2017, Philadelphia, Pennsylvania.
Available from: 2018-05-29 Created: 2018-05-29 Last updated: 2018-05-29Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full text

Authority records BETA

Öberg, Kjell

Search in DiVA

By author/editor
Öberg, Kjell
By organisation
Endocrine Tumor Biology
In the same journal
Pancreas
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 3 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf